About
Porosome Therapeutics develops therapies that target cellular secretory defects by leveraging the atomic structure of the porosome nanomachine using cryo-EM and AI, focusing on diseases such as Alzheimer's, cystic fibrosis, and type 1 diabetes.
Explore Porosome Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.